Naples Global Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
9,370
+45
+0.5% +$8.83K 0.12% 170
2026
Q1
$1.83M Buy
9,325
+88
+1% +$17.1K 0.13% 170
2025
Q4
$1.6M Sell
9,237
-150
-2% -$27.3K 0.12% 186
2025
Q3
$1.79M Buy
9,387
+26
+0.3% +$4.61K 0.14% 172
2025
Q2
$1.68M Buy
9,361
+55
+0.6% +$9.55K 0.14% 171
2025
Q1
$1.57M Buy
9,306
+1,300
+16% +$214K 0.15% 174
2024
Q4
$1.21M Buy
8,006
+100
+1% +$15.6K 0.11% 198
2024
Q3
$1.23M Sell
7,906
-100
-1% -$14.9K 0.11% 202
2024
Q2
$1.1M Buy
8,006
+100
+1% +$13.7K 0.11% 206
2024
Q1
$1.05M Buy
7,906
+1,735
+28% +$225K 0.11% 210
2023
Q4
$851K Buy
6,171
+90
+1% +$11.8K 0.09% 228
2023
Q3
$741K Buy
6,081
+751
+14% +$100K 0.09% 239
2023
Q2
$749K Buy
5,330
+260
+5% +$35.8K 0.09% 233
2023
Q1
$717K Buy
5,070
+5
+0.1% +$715 0.09% 240
2022
Q4
$792K Sell
5,065
-250
-5% -$35.9K 0.1% 230
2022
Q3
$652K Buy
5,315
+480
+10% +$63.2K 0.09% 241
2022
Q2
$643K Buy
4,835
+415
+9% +$56.5K 0.08% 249
2022
Q1
$605K Buy
4,420
+2,265
+105% +$316K 0.07% 260
2021
Q4
$373K Buy
2,155
+215
+11% +$32.7K 0.04% 314
2021
Q3
$282K Buy
1,940
+100
+5% +$14.6K 0.04% 340
2021
Q2
$243K Buy
+1,840
New +$241K 0.03% 353

Other funds holding DGX

Naples Global Advisors's DGX Position: Q2 2026 in Review

Naples Global Advisors increased its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, buying an estimated $8.83K and bringing the position to 9,370 shares worth $1.99M. The position accounts for 0.12% of the portfolio, ranked #170.

Naples Global Advisors first reported a position in DGX in Q2 2021 and has held it in 21 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Naples Global Advisors held 9,370 shares of Quest Diagnostics worth $1.99M as of Q2 2026.
  • Naples Global Advisors bought 45 Quest Diagnostics shares in Q2 2026, an estimated $8.83K.
  • Quest Diagnostics made up 0.12% of Naples Global Advisors's portfolio in Q2 2026, its #170 holding.
  • Naples Global Advisors first reported a position in Quest Diagnostics in Q2 2021 and has held it in 21 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.